1. G. A. Voronina and S. B. Seredenin, Guidelines for Experimental (preclinical) Studies of New Pharmacological Substances [in Russian], Meditsina, Moscow (2000), pp. 126–130.
2. V. E. Gmiro and S. E. Serdyuk, “Comparative analysis of NMDA-blocking activity and the safety of monocationic compounds in animal experiments,” Eksperim. Klin. Farmakol., 63, No. 6, 3–8 (2000).
3. S. E. Serdyuk and V. E. Gmiro, “Analgesic and antidepressant actions of adrenaline stress in endogenous activation of the afferent systems of the stomach in rats,” Ros. Fiziol. Zh. im. I. M. Sechenova, 83, No. 8, 111–120 (1997).
4. S. E. Serdyuk and V. E. Gmiro, “Adrenaline potentiates the analgesic and antidepressant actions of polyvinylpyrrolidone and cholecystokinin due to stimulation of gastric mucosal afferents,” Byull. Eksperim. Biol. Med., 143, No. 3, 321–323 (2007).
5. S. E. Serdyuk and V. E. Gmiro, “Adrenaline potentiates the analgesic and antidepressant actions of amitriptyline due to stimulation of gastric mucosal afferents,” Byull. Eksperim. Biol. Med., 144, No. 11, 535–537 (2007).